Carbamazepine

Generic name: Pronounced as (kar ba maz' e peen)
Brand names
  • Carbatrol®
  • Epitol®
  • Equetro®
  • Tegretol®
  • Tegretol®-XR
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 05/15/2020

Carbamazepine may cause life-threatening allergic reactions called Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). These allergic reactions may cause severe damage to the skin and internal organs. The risk of SJS or TEN is highest in people of Asian ancestry who have a genetic (inherited) risk factor. If you are Asian, your doctor will usually order a test to see if you have the genetic risk factor before prescribing carbamazepine. If you do not have this genetic risk factor, your doctor may prescribe carbamazepine, but there is still a slight risk that you will develop SJS or TEN. Call your doctor immediately if you develop a painful rash, hives, blistering or peeling of skin, easy bruising, mouth sores, or a fever during your treatment with carbamazepine. Stevens-Johnson syndrome or toxic epidermal necrolysis usually occurs during the first few months of treatment with carbamazepine.

Carbamazepine may decrease the number of blood cells produced by your body. In rare cases, the number of blood cells may decrease enough to cause serious or life-threatening health problems. Tell your doctor if you have ever had bone marrow depression (decreased number of blood cells) or any other blood disorders, especially if it was caused by another medication. If you experience any of the following symptoms, call your doctor immediately: sore throat, fever, chills, or other signs of infection that come and go or do not go away; shortness of breath; fatigue; unusual bleeding or bruising such as heavy menstrual bleeding, nose bleeds, or bleeding gums; tiny red or purple dots or spots on the skin; or mouth sores..

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests before and during your treatment to check your body's response to carbamazepine.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with carbamazepine and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

Carbamazepine is used alone or in combination with other medications to control certain types of seizures in people with epilepsy. It is also used to treat trigeminal neuralgia (a condition that causes facial nerve pain). Carbamazepine extended-release capsules (Equetro brand only) are also used to treat episodes of mania (frenzied, abnormally excited or irritated mood) or mixed episodes (symptoms of mania and depression that happen at the same time) in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Carbamazepine is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.

Carbamazepine comes as a tablet, a chewable tablet, an extended-release (long-acting) tablet, an extended-release capsule, and as a suspension (liquid) to take by mouth. The regular tablet, chewable tablet, and suspension are usually taken two to four times a day with meals. The extended-release tablet (Tegretol XR) is usually taken twice a day with meals. The extended-release capsule (Carbatrol, Equetro) is usually taken twice a day with or without meals. To help you remember to take carbamazepine, take it at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take carbamazepine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release tablets whole; do not split, chew, or crush them. The extended-release capsules may be opened and the beads inside sprinkled over food, such as a teaspoon of applesauce or similar food. Do not crush or chew the extended-release capsules or the beads inside them.

Shake the suspension well before each use to mix the medication evenly.

Your doctor will start you on a low dose of carbamazepine and gradually increase your dose.

Carbamazepine may help control your condition but will not cure it. It may take a few weeks or longer before you feel the full benefit of carbamazepine. Continue to take carbamazepine even if you feel well. Do not stop taking carbamazepine without talking to your doctor, even if you experience side effects such as unusual changes in behavior or mood. If you have a seizure disorder and you suddenly stop taking carbamazepine, your seizures may become worse. Your doctor will probably decrease your dose gradually.

Carbamazepine is also sometimes used to treat mental illnesses, depression, posttraumatic stress disorder, drug and alcohol withdrawal, restless legs syndrome, diabetes insipidus, certain pain syndromes, and a disease in children called chorea. Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking carbamazepine,

  • tell your doctor and pharmacist if you are allergic (rash, wheezing, hives, difficulty swallowing or breathing, swelling of your face, eyes, eyelids, lips, or tongue) to carbamazepine, amitriptyline (Elavil), amoxapine, clomipramine (Anafranil), desipramine (Norpramin), doxepin (Silenor, Zonalon), imipramine (Tofranil), nortriptyline (Pamelor), oxcarbazepine (Trileptal), protriptyline (Vivactil), other medications for seizures such as phenobarbital, phenytoin (Dilantin, Phenytek), or primidone (Mysoline), any other medications, or any of the ingredients in carbamazepine preparations. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor if you are taking nefazadone or certain non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as delavirdine (Rescriptor). Your doctor will probably tell you not take carbamazepine with these medications. Also, tell your doctor if you are taking a monoamine oxidase (MAO) inhibitor such as isocarboxazid (Marplan), linezolid (Zyvox), methylene blue, phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate), or if you have stopped taking an MAO inhibitor within the past 14 days. Your doctor will probably tell you not to take carbamazepine. If you stop taking carbamazepine, you should wait at least 14 days before you start to take an MAO inhibitor.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: acetaminophen (Tylenol); acetazolamide (Diamox); albendazole (Albenza); alprazolam (Panax); aminophylline; anticoagulants ('blood thinners') such as apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa), rivaroxaban (Xarelto), and warfarin (Coumadin, Jantoven); antidepressants such as amitriptyline (Elavil), bupropion (Wellbutrin, Zyban), buspirone (BuSpar), citalopram (Celexa), clomipramine (Anafranil), desipramine (Norpramin), fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), mirtazapine (Remeron), nortriptyline (Pamelor); antifungals such as fluconazole (Diflucan), itraconazole (Onmel, Sporanox), ketoconazole, and voriconazole (Vfend); aprepitant (Emend); aripiprazole (Abilify); buprenorphine (Butrans, Sublocade); bupropion (Aplenzin, Wellbutrin, Zyban); cimetidine (Tagamet); ciprofloxacin; cisplatin (Platinol); corticosteroids such as dexamethasone and prednisolone (Prelone); clarithromycin (Biaxin, in Prevpac); clonazepam (Klonopin); clozapine (Clozaril); cyclophosphamide; cyclosporine (Gengraf, Neoral, Sandimmune); dalfopristin and quinupristin (Synercid); danazol (Danocrine); dantrolene (Dantrium); diltiazem (Cardizem, Diltzac, Tiazac, others); diuretics (water pills); doxorubicin (Adriamycin, Rubex); doxycycline (Vibramycin); erythromycin (E.E.S., E-Mycin, Erythrocin); eslicarbazepine (Aptiom); everolimus (Afinitor, Zortress); felodipine (Plendil); haloperidol (Haldol); HIV protease inhibitors including atazanavir (Reyataz), indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Fortovase, Invirase); ibuprofen (Advil); imatinib (Gleevec); isoniazid (INH, Laniazid, in Rifater); levothyroxine (Levoxyl, Synthroid); lithium (Lithobid); loratadine (Claritin); lorazepam (Ativan); loxapine (Adasuve); certain medications to treat malaria such as chloroquine (Aralen) and mefloquine; medications for anxiety or mental illness; other medications for seizures such as ethosuximide (Zarontin), felbamate (Felbatol), fosphenytoin (Cerebyx); lamotrigine (Lamictal), methsuximide (Celontin), oxcarbazepine (Trileptal), phenobarbital, phensuximide (Milontin) (not available in the US), phenytoin (Dilantin, Phenytek), primidone (Mysoline), tiagabine (Gabitril), topiramate (Topamax), and valproic acid (Depakene, Depakote); lapatinib; methadone (Dolophine, Methadose); midazolam; niacinamide (nicotinamide, Vitamin B3); olanzapine; omeprazole; oxybutynin; propoxyphene (Darvon); praziquantel (Biltricide); quetiapine; quinine; rifampin (Rifadin, Rimactane); risperidone; sedatives; sertraline (Zoloft); sirolimus; sleeping pills; tacrolimus (Prograf); tadalafil (Adcirca, Cialis); temsirolimus (Torisel); terfenadine (Seldane) (not available in the US); theophylline (Theo-24, Theochron, others); ticlopidine; tramadol (Ultram); tranquilizers; trazodone; troleandomycin (TAO); verapamil (Calan, Verelan); zileuton (Zyflo); ziprasidone (Geodon), and zonisamide (Zonegran). Many other medications may also interact with carbamazepine, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking any other liquid medications, do not take them at the same time as carbamazepine suspension.

  • tell your doctor if you have or have ever had glaucoma (a condition in which increased pressure in the eye can lead to gradual loss of vision); or heart, kidney, thyroid, or liver disease.

  • you should know that carbamazepine may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, injections, implants, or intrauterine devices). Use another form of birth control while taking carbamazepine. Tell your doctor if you have unexpected vaginal bleeding or think you may be pregnant while you are taking carbamazepine.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Carbamazepine may harm the fetus. If you become pregnant while taking carbamazepine, call your doctor immediately.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking carbamazepine.

  • you should know that carbamazepine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

  • you should know that your mental health may change in unexpected ways and you may become suicidal (thinking about harming or killing yourself or planning or trying to do so) while you are taking carbamazepine for the treatment of epilepsy, mental illness, or other conditions. A small number of adults and children 5 years of age and older (about 1 in 500 people) who took anticonvulsants such as carbamazepine to treat various conditions during clinical studies became suicidal during their treatment. Some of these people developed suicidal thoughts and behavior as early as one week after they started taking the medication. There is a risk that you may experience changes in your mental health if you take an anticonvulsant medication such as carbamazepine, but there may also be a risk that you will experience changes in your mental health if your condition is not treated. You and your doctor will decide whether the risks of taking an anticonvulsant medication are greater than the risks of not taking the medication. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: panic attacks; agitation or restlessness; new or worsening irritability, anxiety, or depression; acting on dangerous impulses; difficulty falling or staying asleep; aggressive, angry, or violent behavior; mania (frenzied, abnormally excited mood); talking or thinking about wanting to hurt yourself or end your life; withdrawing from friends and family; preoccupation with death and dying; giving away prized possessions; or any other unusual changes in behavior or mood. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.

  • if you have fructose intolerance (an inherited condition in which the body lacks the protein needed to break down fructose [a fruit sugar found in certain sweeteners such as sorbitol]), you should know that the oral suspension is sweetened with sorbitol. Tell your doctor if you have fructose intolerance.

Talk to your doctor about eating grapefruit or drinking grapefruit juice while taking this medicine.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Carbamazepine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness

    • thinking abnormal

    • difficulty speaking

    • uncontrollable shaking of a part of the body

    • constipation

    • dry mouth

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING and SPECIAL PRECAUTION sections, call your doctor immediately:

    • confusion

    • rash

    • fast, slow, or pounding heartbeat

    • yellowing of the skin or eyes

    • dark urine

    • pain on the right side of your stomach area

    • loss of appetite

    • nausea

    • vomiting

    • vision changes

    • fatigue

    • swelling of your face, eyes, eyelids, lips, or tongue

    • difficulty swallowing or breathing

    • headache, new or increased number of seizures, difficulty concentrating, confusion, weakness, or unsteadiness

    • severe rash with one or more of the following: fever, muscle or joint aches, red or swollen eyes, blisters or peeling skin, mouth sores, or swelling of your face or neck

  • Carbamazepine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature, away from light, excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • unconsciousness

  • seizures

  • restlessness

  • muscle twitching

  • abnormal movements

  • shaking of a part of your body that you cannot control

  • unsteadiness

  • drowsiness

  • dizziness

  • vision changes

  • irregular or slowed breathing

  • rapid or pounding heartbeat

  • nausea

  • vomiting

  • difficulty urinating

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking carbamazepine.

Carbamazepine can interfere with the results of home pregnancy tests. Talk to your doctor if you think you might be pregnant while you are taking carbamazepine. Do not try to test for pregnancy at home.

The extended-release tablet does not dissolve in the stomach after swallowing. It slowly releases the medicine as it passes through your digestive system. You may notice the tablet coating in your stool.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Leflunomide is combined with Carbamazepine.
Delavirdine Delavirdine The metabolism of Carbamazepine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Carbamazepine can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Carbamazepine can be decreased when combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dolasetron.
Aminophylline Aminophylline The serum concentration of Aminophylline can be decreased when it is combined with Carbamazepine.
Anagrelide Anagrelide The metabolism of Anagrelide can be increased when combined with Carbamazepine.
Cilostazol Cilostazol The serum concentration of Cilostazol can be increased when it is combined with Carbamazepine.
Clopidogrel Clopidogrel The metabolism of Carbamazepine can be decreased when combined with Clopidogrel.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Carbamazepine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Conjugated estrogens can be increased when combined with Carbamazepine.
Fenofibrate Fenofibrate The metabolism of Carbamazepine can be increased when combined with Fenofibrate.
Guanfacine Guanfacine The metabolism of Guanfacine can be increased when combined with Carbamazepine.
Magnesium Gluconate Magnesium Gluconate Magnesium gluconate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methylergonovine Methylergonovine The metabolism of Carbamazepine can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate The metabolism of Mycophenolic acid can be increased when combined with Carbamazepine.
Naratriptan Naratriptan The risk or severity of adverse effects can be increased when Carbamazepine is combined with Naratriptan.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Carbamazepine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pentazocine.
Potassium Potassium Carbamazepine may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Carbamazepine is combined with Prednisone.
Ranitidine Ranitidine The metabolism of Ranitidine can be increased when combined with Carbamazepine.
Reserpine Reserpine The metabolism of Carbamazepine can be increased when combined with Reserpine.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Carbamazepine.
Tizanidine Tizanidine Carbamazepine may increase the Change in thyroid function activities of Tizanidine.
Triamcinolone Triamcinolone The metabolism of Carbamazepine can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Carbamazepine.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection The metabolism of Carbamazepine can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The metabolism of Carbamazepine can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Carbamazepine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carbamazepine.
Levofloxacin Injection Levofloxacin Injection Carbamazepine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The metabolism of Carbamazepine can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Carbamazepine can be increased when combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Carbamazepine.
Metronidazole Injection Metronidazole Injection The metabolism of Carbamazepine can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Carbamazepine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Vancomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Carbamazepine.
Altretamine Altretamine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cyclosporine Cyclosporine The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.
Ondansetron Ondansetron The metabolism of Ondansetron can be decreased when combined with Carbamazepine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Carbamazepine.
Granisetron Granisetron The risk or severity of adverse effects can be increased when Carbamazepine is combined with Granisetron.
Torsemide Torsemide Torasemide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The metabolism of Carbamazepine can be increased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Alosetron can be increased when combined with Carbamazepine.
Dofetilide Dofetilide The metabolism of Dofetilide can be increased when combined with Carbamazepine.
Entacapone Entacapone The risk or severity of adverse effects can be increased when Entacapone is combined with Carbamazepine.
Hydroxychloroquine Hydroxychloroquine The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Hydroxychloroquine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Orlistat Orlistat Orlistat can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxcarbazepine Oxcarbazepine The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Carbamazepine resulting in a loss in efficacy.
Pantoprazole Pantoprazole Carbamazepine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Carbamazepine is combined with Temozolomide.
Zaleplon Zaleplon Carbamazepine may increase the Change in thyroid function activities of Zaleplon.
Anakinra Anakinra The metabolism of Carbamazepine can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desloratadine.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Carbamazepine.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Carbamazepine.
Trimipramine Trimipramine The metabolism of Trimipramine can be increased when combined with Carbamazepine.
Etanercept Injection Etanercept Injection The metabolism of Carbamazepine can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Carbamazepine can be increased when combined with Modafinil.
Perindopril Perindopril Perindopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tenofovir Tenofovir The serum concentration of Tenofovir can be decreased when it is combined with Carbamazepine.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sirolimus Sirolimus The metabolism of Carbamazepine can be decreased when combined with Sirolimus.
Dutasteride Dutasteride The metabolism of Carbamazepine can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Carbamazepine can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Carbamazepine.
Eplerenone Eplerenone The metabolism of Carbamazepine can be decreased when combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Escitalopram.
Zonisamide Zonisamide Carbamazepine may increase the Change in thyroid function activities of Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Carbamazepine can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Carbamazepine.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dexmethylphenidate.
Ezetimibe Ezetimibe The metabolism of Ezetimibe can be increased when combined with Carbamazepine.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Glatiramer.
Atazanavir Atazanavir The serum concentration of Carbamazepine can be decreased when it is combined with Atazanavir.
Almotriptan Almotriptan Carbamazepine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Carbamazepine.
Mefloquine Mefloquine The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Mefloquine.
Rosuvastatin Rosuvastatin The metabolism of Carbamazepine can be decreased when combined with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Carbamazepine.
Aprepitant Aprepitant The metabolism of Carbamazepine can be decreased when combined with Aprepitant.
Emtricitabine Emtricitabine Carbamazepine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Carbamazepine may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Tegaserod.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Carbamazepine.
Fosamprenavir Fosamprenavir The serum concentration of Carbamazepine can be decreased when it is combined with Fosamprenavir.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be increased when combined with Carbamazepine.
Progesterone Progesterone The serum concentration of Progesterone can be decreased when it is combined with Carbamazepine.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Carbamazepine.
Infliximab Injection Infliximab Injection The metabolism of Carbamazepine can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The therapeutic efficacy of Carbamazepine can be increased when used in combination with Oxandrolone.
Protriptyline Protriptyline The risk or severity of adverse effects can be increased when Protriptyline is combined with Carbamazepine.
Rifaximin Rifaximin The metabolism of Carbamazepine can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Carbamazepine can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The serum concentration of Norethisterone can be decreased when it is combined with Carbamazepine.
Tinidazole Tinidazole Carbamazepine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan The metabolism of Carbamazepine can be increased when combined with Bosentan.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be increased when combined with Carbamazepine.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be increased when combined with Carbamazepine.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Carbamazepine is combined with Eszopiclone.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Solifenacin Solifenacin Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Carbamazepine can be decreased when combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Amphetamine.
Entecavir Entecavir The metabolism of Entecavir can be increased when combined with Carbamazepine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carbamazepine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carbamazepine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Isocarboxazid Isocarboxazid The risk or severity of adverse effects can be increased when Carbamazepine is combined with Isocarboxazid.
Ramelteon Ramelteon The metabolism of Ramelteon can be increased when combined with Carbamazepine.
Darifenacin Darifenacin Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Carbamazepine.
Deferasirox Deferasirox The metabolism of Deferasirox can be increased when combined with Carbamazepine.
Tipranavir Tipranavir The serum concentration of Carbamazepine can be decreased when it is combined with Tipranavir.
Felbamate Felbamate The serum concentration of Felbamate can be decreased when it is combined with Carbamazepine.
Ranolazine Ranolazine The metabolism of Carbamazepine can be increased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Carbamazepine can be increased when combined with Abatacept.
Rasagiline Rasagiline The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rasagiline.
Imatinib Imatinib The metabolism of Imatinib can be increased when combined with Carbamazepine.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Carbamazepine.
Gefitinib Gefitinib The metabolism of Gefitinib can be increased when combined with Carbamazepine.
Albuterol Albuterol Carbamazepine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Paliperidone can be decreased when combined with Carbamazepine.
Exemestane Exemestane The metabolism of Exemestane can be increased when combined with Carbamazepine.
Bortezomib Bortezomib The metabolism of Bortezomib can be increased when combined with Carbamazepine.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Carbamazepine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Carbamazepine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Carbamazepine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Carbamazepine.
Fulvestrant Injection Fulvestrant Injection The metabolism of Fulvestrant can be increased when combined with Carbamazepine.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Carbamazepine.
Posaconazole Posaconazole The metabolism of Carbamazepine can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Carbamazepine can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Carbamazepine.
Darunavir Darunavir The serum concentration of Carbamazepine can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pemetrexed.
Dimenhydrinate Dimenhydrinate The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Lisdexamfetamine.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Retapamulin Retapamulin The metabolism of Retapamulin can be increased when combined with Carbamazepine.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Carbamazepine can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Carbamazepine can be decreased when combined with Sunitinib.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Lapatinib Lapatinib The metabolism of Lapatinib can be increased when combined with Carbamazepine.
Levocetirizine Levocetirizine Carbamazepine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be increased when combined with Carbamazepine.
Mexiletine Mexiletine The metabolism of Mexiletine can be increased when combined with Carbamazepine.
Armodafinil Armodafinil The metabolism of Carbamazepine can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Azacitidine.
Ivermectin Ivermectin The metabolism of Carbamazepine can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The metabolism of Carbamazepine can be decreased when combined with Temsirolimus.
Maraviroc Maraviroc The metabolism of Maraviroc can be increased when combined with Carbamazepine.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Carbamazepine.
Nilotinib Nilotinib The metabolism of Carbamazepine can be decreased when combined with Nilotinib.
Raltegravir Raltegravir The metabolism of Raltegravir can be increased when combined with Carbamazepine.
Bexarotene Bexarotene The metabolism of Carbamazepine can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Carbamazepine can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Carbamazepine can be decreased when combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Decitabine.
Desmopressin Desmopressin The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desmopressin.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Carbamazepine.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbamazepine.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Etravirine Etravirine The metabolism of Carbamazepine can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Carbamazepine.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Carbamazepine can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Carbamazepine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Carbamazepine.
Tretinoin Tretinoin The metabolism of Carbamazepine can be decreased when combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Carbamazepine.
Leucovorin Injection Leucovorin Injection The serum concentration of Carbamazepine can be decreased when it is combined with Leucovorin.
Pilocarpine Pilocarpine The metabolism of Carbamazepine can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be increased when combined with Carbamazepine.
Certolizumab Injection Certolizumab Injection The metabolism of Carbamazepine can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Carbamazepine can be decreased when combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be increased when combined with Carbamazepine.
Levoleucovorin Injection Levoleucovorin Injection The serum concentration of Carbamazepine can be decreased when it is combined with Levoleucovorin.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be increased when combined with Carbamazepine.
Mitotane Mitotane The metabolism of Carbamazepine can be increased when combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Carbamazepine.
Rufinamide Rufinamide The serum concentration of Carbamazepine can be decreased when it is combined with Rufinamide.
Midazolam Midazolam The metabolism of Midazolam can be decreased when combined with Carbamazepine.
Naltrexone Injection Naltrexone Injection The metabolism of Naltrexone can be increased when combined with Carbamazepine.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Carbamazepine.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be increased when combined with Carbamazepine.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Carbamazepine.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Carbamazepine.
Dexlansoprazole Dexlansoprazole The metabolism of Dexlansoprazole can be decreased when combined with Carbamazepine.
Plerixafor Injection Plerixafor Injection Plerixafor may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Sodium phosphate, monobasic.
Fesoterodine Fesoterodine Fesoterodine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Betaxolol Betaxolol The metabolism of Betaxolol can be increased when combined with Carbamazepine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Carbamazepine.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Lacosamide Lacosamide The serum concentration of Lacosamide can be decreased when it is combined with Carbamazepine.
Everolimus Everolimus The metabolism of Carbamazepine can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Carbamazepine can be increased when combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Carbamazepine can be increased when combined with Dronedarone.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Carbamazepine.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Saxagliptin Saxagliptin The metabolism of Carbamazepine can be decreased when combined with Saxagliptin.
Telavancin Injection Telavancin Injection Telavancin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Carbamazepine can be decreased when combined with Romidepsin.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Topotecan Topotecan Carbamazepine may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.
Golimumab Injection Golimumab Injection The metabolism of Carbamazepine can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Carbamazepine.
Asenapine Asenapine The metabolism of Asenapine can be increased when combined with Carbamazepine.
Vigabatrin Vigabatrin Carbamazepine may increase the Change in thyroid function activities of Vigabatrin.
Albendazole Albendazole The metabolism of Albendazole can be increased when combined with Carbamazepine.
Ulipristal Ulipristal The metabolism of Ulipristal can be increased when combined with Carbamazepine.
Levonorgestrel Levonorgestrel The serum concentration of Levonorgestrel can be decreased when it is combined with Carbamazepine.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxymorphone.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Carbamazepine.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Carbamazepine.
Tocilizumab Injection Tocilizumab Injection The metabolism of Tocilizumab can be increased when combined with Carbamazepine.
Dalfampridine Dalfampridine Dalfampridine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Fingolimod Fingolimod The serum concentration of Fingolimod can be decreased when it is combined with Carbamazepine.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eribulin.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Carbamazepine.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Carbamazepine can be decreased when combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The metabolism of Carbamazepine can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Vilazodone can be increased when combined with Carbamazepine.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Carbamazepine can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Carbamazepine.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Carbamazepine.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Carbamazepine.
Linagliptin Linagliptin The metabolism of Linagliptin can be decreased when combined with Carbamazepine.
Rilpivirine Rilpivirine The serum concentration of Rilpivirine can be decreased when it is combined with Carbamazepine.
Telaprevir Telaprevir The metabolism of Carbamazepine can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Carbamazepine can be increased when combined with Cyclophosphamide.
Abiraterone Abiraterone The metabolism of Abiraterone can be increased when combined with Carbamazepine.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Carbamazepine.
Ticagrelor Ticagrelor The metabolism of Carbamazepine can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Carbamazepine can be decreased when combined with Brentuximab vedotin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Carbamazepine.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Carbamazepine.
Clobazam Clobazam Clobazam may increase the Change in thyroid function activities of Carbamazepine.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Carbamazepine.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Belatacept.
Ivacaftor Ivacaftor The serum concentration of Ivacaftor can be decreased when it is combined with Carbamazepine.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Carbamazepine.
Deferiprone Deferiprone Carbamazepine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Carbamazepine can be decreased when combined with Axitinib.
Crizotinib Crizotinib The metabolism of Carbamazepine can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Carbamazepine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Carbamazepine can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Carbamazepine can be decreased when combined with Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Ezogabine Ezogabine Carbamazepine may increase the Change in thyroid function activities of Tiagabine.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Carbamazepine.
Enzalutamide Enzalutamide The metabolism of Carbamazepine can be decreased when combined with Enzalutamide.
Asparaginase Erwinia Chrysanthemi Injection Asparaginase Erwinia Chrysanthemi Injection The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Erwinia chrysanthemi.
Mirabegron Mirabegron Carbamazepine may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Carbamazepine can be decreased when combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Carbamazepine can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Carbamazepine can be increased when combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Carbamazepine is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be increased when combined with Carbamazepine.
Teduglutide Injection Teduglutide Injection Teduglutide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Carbamazepine.
Tofacitinib Tofacitinib Carbamazepine may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin Carbamazepine may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Carbamazepine can be decreased when combined with Ponatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Carbamazepine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Carbamazepine can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The metabolism of Carbamazepine can be decreased when combined with Apixaban.
Canagliflozin Canagliflozin The metabolism of Canagliflozin can be increased when combined with Carbamazepine.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Carbamazepine can be increased when combined with Dabrafenib.
Trametinib Trametinib The metabolism of Carbamazepine can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The metabolism of Dolutegravir can be increased when combined with Carbamazepine.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Carbamazepine.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Carbamazepine.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Carbamazepine.
Ibrutinib Ibrutinib The metabolism of Carbamazepine can be decreased when combined with Ibrutinib.
Lomitapide Lomitapide The metabolism of Carbamazepine can be decreased when combined with Lomitapide.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Carbamazepine can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Sofosbuvir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be increased when combined with Carbamazepine.
Apremilast Apremilast The metabolism of Apremilast can be increased when combined with Carbamazepine.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Carbamazepine can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Siltuximab can be increased when combined with Carbamazepine.
Eslicarbazepine Eslicarbazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The metabolism of Belinostat can be increased when combined with Carbamazepine.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Carbamazepine.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Carbamazepine.
Oritavancin Injection Oritavancin Injection The metabolism of Carbamazepine can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The metabolism of Carbamazepine can be increased when combined with Vorapaxar.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be increased when combined with Carbamazepine.
Suvorexant Suvorexant Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Edoxaban Edoxaban Edoxaban may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Carbamazepine.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Blinatumomab.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Carbamazepine can be increased when combined with Tasimelteon.
Lanreotide Injection Lanreotide Injection The metabolism of Carbamazepine can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The serum concentration of Carbamazepine can be decreased when it is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Carbamazepine can be increased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection The metabolism of Carbamazepine can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.
Palbociclib Palbociclib The metabolism of Carbamazepine can be decreased when combined with Palbociclib.
Lenvatinib Lenvatinib The metabolism of Carbamazepine can be increased when combined with Lenvatinib.
Panobinostat Panobinostat The metabolism of Carbamazepine can be increased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The metabolism of Carbamazepine can be increased when combined with Haloperidol.
Amiloride Amiloride Amiloride may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The metabolism of Carbamazepine can be increased when combined with Isavuconazonium.
Macitentan Macitentan Carbamazepine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Carbamazepine.
Flibanserin Flibanserin The risk or severity of adverse effects can be increased when Carbamazepine is combined with Flibanserin.
Prednisolone Prednisolone The metabolism of Carbamazepine can be increased when combined with Prednisolone.
Daclatasvir Daclatasvir The metabolism of Carbamazepine can be decreased when combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be increased when combined with Carbamazepine.
Ziprasidone Injection Ziprasidone Injection The serum concentration of Carbamazepine can be decreased when it is combined with Ziprasidone.
Cariprazine Cariprazine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Procaine benzylpenicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Eluxadoline.
Cobimetinib Cobimetinib The metabolism of Carbamazepine can be increased when combined with Cobimetinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Carbamazepine.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Carbamazepine.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Carbamazepine.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Carbamazepine.
Rifapentine Rifapentine The metabolism of Carbamazepine can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Carbamazepine can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Carbamazepine can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Carbamazepine can be increased when combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Carbamazepine.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Carbamazepine may increase the Change in thyroid function activities of Brivaracetam.
Venetoclax Venetoclax The metabolism of Carbamazepine can be decreased when combined with Venetoclax.
Cobicistat Cobicistat The metabolism of Cobicistat can be increased when combined with Carbamazepine.
Pimavanserin Pimavanserin The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pimavanserin.
Diphenhydramine Injection Diphenhydramine Injection Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Rucaparib Rucaparib The metabolism of Carbamazepine can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Lixisenatide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Carbamazepine can be decreased when combined with Ribociclib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Carbamazepine can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be increased when combined with Carbamazepine.
Deutetrabenazine Deutetrabenazine The metabolism of Carbamazepine can be decreased when combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Carbamazepine can be decreased when combined with Valbenazine.
Deflazacort Deflazacort The serum concentration of Deflazacort can be decreased when it is combined with Carbamazepine.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Carbamazepine is combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Carbamazepine.
Naldemedine Naldemedine Naldemedine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The metabolism of Carbamazepine can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Carbamazepine can be increased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be increased when combined with Carbamazepine.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Carbamazepine can be increased when combined with Enasidenib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Carbamazepine can be increased when combined with Fosaprepitant.
Benznidazole Benznidazole Benznidazole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Carbamazepine can be decreased when combined with Copanlisib.
Delafloxacin Delafloxacin Carbamazepine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Carbamazepine.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Carbamazepine.
Acalabrutinib Acalabrutinib The metabolism of Carbamazepine can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carbamazepine.
Letermovir Letermovir The metabolism of Carbamazepine can be decreased when combined with Letermovir.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Apalutamide Apalutamide The metabolism of Carbamazepine can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Penicillamine.
Fostamatinib Fostamatinib The metabolism of Carbamazepine can be decreased when combined with Fostamatinib.
Baricitinib Baricitinib The metabolism of Carbamazepine can be increased when combined with Baricitinib.
Lofexidine Lofexidine The therapeutic efficacy of Carbamazepine can be increased when used in combination with Lofexidine.
Plazomicin Injection Plazomicin Injection Plazomicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be increased when combined with Carbamazepine.
Ivosidenib Ivosidenib The metabolism of Carbamazepine can be increased when combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be increased when combined with Carbamazepine.
Doravirine Doravirine The metabolism of Carbamazepine can be decreased when combined with Doravirine.
Cannabidiol Cannabidiol Cannabidiol may increase the Change in thyroid function activities of Carbamazepine.
Dacomitinib Dacomitinib The metabolism of Carbamazepine can be increased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Carbamazepine can be increased when combined with Duvelisib.
Stiripentol Stiripentol Carbamazepine may increase the Change in thyroid function activities of Stiripentol.
Gilteritinib Gilteritinib The metabolism of Carbamazepine can be increased when combined with Gilteritinib.
Lorlatinib Lorlatinib The metabolism of Carbamazepine can be decreased when combined with Lorlatinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Carbamazepine.
Rifamycin Rifamycin The metabolism of Carbamazepine can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Carbamazepine can be increased when combined with Prucalopride.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ravulizumab.
Magnesium Citrate Magnesium Citrate Magnesium citrate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Carbamazepine can be increased when combined with Emapalumab.
Siponimod Siponimod The therapeutic efficacy of Siponimod can be decreased when used in combination with Carbamazepine.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Carbamazepine can be increased when combined with Acyclovir.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Carbamazepine.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be increased when combined with Carbamazepine.
Esomeprazole Injection Esomeprazole Injection The metabolism of Esomeprazole can be decreased when combined with Carbamazepine.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Alpelisib can be decreased when it is combined with Carbamazepine.
Brexanolone Injection Brexanolone Injection Carbamazepine may increase the Change in thyroid function activities of Brexanolone.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Carbamazepine.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be decreased when Carbamazepine is combined with Polatuzumab vedotin.
Solriamfetol Solriamfetol Solriamfetol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Carbamazepine can be decreased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Carbamazepine can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be increased when combined with Carbamazepine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be increased when combined with Carbamazepine.
Upadacitinib Upadacitinib The metabolism of Upadacitinib can be increased when combined with Carbamazepine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Carbamazepine.
Pitolisant Pitolisant The metabolism of Pitolisant can be increased when combined with Carbamazepine.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Carbamazepine.
Lefamulin Lefamulin The metabolism of Lefamulin can be increased when combined with Carbamazepine.
Phenytoin Injection Phenytoin Injection The serum concentration of Carbamazepine can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Carbamazepine can be decreased when it is combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be increased when combined with Carbamazepine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Carbamazepine.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Carbamazepine.
Lasmiditan Lasmiditan The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be decreased when it is combined with Carbamazepine.
Tazemetostat Tazemetostat The metabolism of Carbamazepine can be increased when combined with Tazemetostat.
Cenobamate Cenobamate The serum concentration of Carbamazepine can be decreased when it is combined with Cenobamate.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be increased when combined with Carbamazepine.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ozanimod.
Selumetinib Selumetinib The serum concentration of Selumetinib can be decreased when it is combined with Carbamazepine.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Carbamazepine.
Tucatinib Tucatinib The metabolism of Tucatinib can be increased when combined with Carbamazepine.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Carbamazepine.
Ripretinib Ripretinib The serum concentration of Ripretinib can be decreased when it is combined with Carbamazepine.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Carbamazepine.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Carbamazepine.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Carbamazepine.
Fenfluramine Fenfluramine The serum concentration of Fenfluramine can be decreased when it is combined with Carbamazepine.
Fostemsavir Fostemsavir The serum concentration of Fostemsavir can be decreased when it is combined with Carbamazepine.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be decreased when it is combined with Carbamazepine.
Octreotide Octreotide The serum concentration of Carbamazepine can be increased when it is combined with Octreotide.
Pralsetinib Pralsetinib The serum concentration of Carbamazepine can be decreased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Carbamazepine can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The serum concentration of Relugolix can be decreased when it is combined with Carbamazepine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The serum concentration of Drospirenone can be decreased when it is combined with Carbamazepine.
Viloxazine Viloxazine Carbamazepine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Carbamazepine can be increased when combined with Vitamin E.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Theophylline Theophylline The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Carbamazepine.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Naproxen Naproxen The metabolism of Carbamazepine can be increased when combined with Naproxen.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Trazodone Trazodone The serum concentration of Trazodone can be decreased when it is combined with Carbamazepine.
Isotretinoin Isotretinoin Carbamazepine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Carbamazepine.
Phenobarbital Phenobarbital Carbamazepine may increase the Change in thyroid function activities of Phenobarbital.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Carbamazepine can be increased when combined with Methotrexate.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levorphanol.
Primidone Primidone Carbamazepine may increase the Change in thyroid function activities of Primidone.
Methsuximide Methsuximide Carbamazepine may increase the Change in thyroid function activities of Methsuximide.
Diethylpropion Diethylpropion The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Carbamazepine can be increased when combined with Chlorpromazine.
Diazepam Diazepam Carbamazepine may increase the Change in thyroid function activities of Diazepam.
Oxazepam Oxazepam Carbamazepine may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Carbamazepine may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Carbamazepine may increase the Change in thyroid function activities of Clorazepic acid.
Lorazepam Lorazepam Lorazepam may increase the Change in thyroid function activities of Carbamazepine.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Carbamazepine.
Amantadine Amantadine Amantadine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Meprobamate Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Carbamazepine.
Chlordiazepoxide Chlordiazepoxide The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Carbamazepine.
Bromocriptine Bromocriptine The metabolism of Carbamazepine can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tranylcypromine.
Phenelzine Phenelzine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procarbazine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ergoloid mesylate.
Tetracycline Tetracycline The metabolism of Carbamazepine can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Carbamazepine.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Prochlorperazine Prochlorperazine The metabolism of Carbamazepine can be increased when combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be increased when combined with Carbamazepine.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Carbamazepine.
Dapsone Dapsone The metabolism of Carbamazepine can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine Carbamazepine may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Oxycodone Oxycodone The metabolism of Carbamazepine can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Methadone can be increased when combined with Carbamazepine.
Oxybutynin Oxybutynin The metabolism of Carbamazepine can be decreased when combined with Oxybutynin.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Maprotiline Maprotiline The metabolism of Maprotiline can be increased when combined with Carbamazepine.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be increased when combined with Carbamazepine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Azathioprine.
Fluphenazine Fluphenazine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fluphenazine.
Phentermine Phentermine The metabolism of Carbamazepine can be increased when combined with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Amoxapine Amoxapine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Carbamazepine.
Hydrocortisone Hydrocortisone The metabolism of Carbamazepine can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Carbamazepine.
Doxorubicin Doxorubicin The metabolism of Carbamazepine can be decreased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Molindone Molindone The risk or severity of adverse effects can be increased when Carbamazepine is combined with Molindone.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Carbamazepine.
Hydralazine Hydralazine The metabolism of Carbamazepine can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Carbamazepine can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Carbamazepine.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Carbamazepine.
Loperamide Loperamide The metabolism of Carbamazepine can be decreased when combined with Loperamide.
Promethazine Promethazine Carbamazepine may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Daunorubicin Daunorubicin The metabolism of Carbamazepine can be decreased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Carbamazepine can be increased when combined with Griseofulvin.
Digoxin Digoxin Digoxin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Loxapine Loxapine The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be decreased when combined with Carbamazepine.
Quinine Quinine The metabolism of Carbamazepine can be decreased when combined with Quinine.
Ethosuximide Ethosuximide Carbamazepine may increase the Change in thyroid function activities of Ethosuximide.
Calcitriol Calcitriol The metabolism of Carbamazepine can be increased when combined with Calcitriol.
Triamterene Triamterene The metabolism of Carbamazepine can be increased when combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The metabolism of Carbamazepine can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Carbamazepine.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Carbamazepine.
Metolazone Metolazone The risk or severity of adverse effects can be increased when Metolazone is combined with Carbamazepine.
Isosorbide Isosorbide The serum concentration of Isosorbide can be decreased when it is combined with Carbamazepine.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Carbamazepine.
Secobarbital Secobarbital Carbamazepine may increase the Change in thyroid function activities of Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Carbamazepine.
Amitriptyline Amitriptyline The metabolism of Carbamazepine can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Imipramine can be increased when combined with Carbamazepine.
Probenecid Probenecid The metabolism of Carbamazepine can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be increased when combined with Carbamazepine.
Procainamide Procainamide Carbamazepine may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The metabolism of Carbamazepine can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Rifampin Rifampin The metabolism of Rifampicin can be increased when combined with Carbamazepine.
Disopyramide Disopyramide The metabolism of Disopyramide can be increased when combined with Carbamazepine.
Valproic Acid Valproic Acid The serum concentration of carbamazepine-10,11­ epoxide (CBZ-E), an active metabolite of Carbamazepine, can be increased when used in combination with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Carbamazepine can be increased when combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Carbamazepine.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Levothyroxine Levothyroxine The metabolism of Levothyroxine can be increased when combined with Carbamazepine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methimazole Methimazole The metabolism of Carbamazepine can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Carbamazepine.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dextromethorphan Dextromethorphan The metabolism of Carbamazepine can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Carbamazepine is combined with Cyclobenzaprine.
Niacin Niacin The metabolism of Carbamazepine can be decreased when combined with Niacin.
Baclofen Baclofen Baclofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Cyproheptadine Cyproheptadine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.
Clemastine Clemastine The risk or severity of adverse effects can be increased when Clemastine is combined with Carbamazepine.
Chlorpheniramine Chlorpheniramine The metabolism of Carbamazepine can be decreased when combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Carbamazepine.
Meclizine Meclizine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Meclizine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carbamazepine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Carbamazepine.
Dantrolene Dantrolene The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Chlorzoxazone can be increased when combined with Carbamazepine.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Carbamazepine.
Methocarbamol Methocarbamol The risk or severity of adverse effects can be increased when Methocarbamol is combined with Carbamazepine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Folic Acid Folic Acid The serum concentration of Carbamazepine can be decreased when it is combined with Folic acid.
Danazol Danazol The metabolism of Carbamazepine can be decreased when combined with Danazol.
Disulfiram Disulfiram The metabolism of Carbamazepine can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The serum concentration of Propranolol can be decreased when it is combined with Carbamazepine.
Minoxidil Minoxidil The metabolism of Minoxidil can be increased when combined with Carbamazepine.
Pseudoephedrine Pseudoephedrine The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be increased when combined with Carbamazepine.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection The metabolism of Carbamazepine can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The serum concentration of Mercaptopurine can be decreased when it is combined with Carbamazepine.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nalbuphine.
Allopurinol Allopurinol The risk or severity of Stevens-Johnson syndrome can be increased when Allopurinol is combined with Carbamazepine.
Trimethobenzamide Trimethobenzamide The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trimethobenzamide.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carbamazepine.
Colchicine Colchicine The metabolism of Carbamazepine can be increased when combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Carbamazepine can be increased when combined with Cephalexin.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dacarbazine.
Acetazolamide Acetazolamide The serum concentration of Carbamazepine can be increased when it is combined with Acetazolamide.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Carbamazepine.
Ketoconazole Ketoconazole The metabolism of Carbamazepine can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Pyrantel may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be increased when combined with Carbamazepine.
Vincristine Injection Vincristine Injection The metabolism of Carbamazepine can be decreased when combined with Vincristine.
Dipyridamole Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Carbamazepine.
Vinblastine Vinblastine The metabolism of Carbamazepine can be increased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Carbamazepine can be increased when combined with Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Thiothixene Thiothixene The metabolism of Thiothixene can be increased when combined with Carbamazepine.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Carbamazepine.
Alprazolam Alprazolam The metabolism of Carbamazepine can be decreased when combined with Alprazolam.
Temazepam Temazepam Temazepam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Triazolam Triazolam The metabolism of Triazolam can be decreased when combined with Carbamazepine.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Hyoscyamine Hyoscyamine Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Propantheline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Diltiazem Diltiazem The metabolism of Carbamazepine can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Carbamazepine.
Timolol Timolol Timolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Verapamil Verapamil The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.
Pindolol Pindolol Pindolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Carbamazepine.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Carbamazepine.
Etoposide Etoposide The metabolism of Carbamazepine can be increased when combined with Etoposide.
Glyburide Glyburide The metabolism of Carbamazepine can be decreased when combined with Glyburide.
Glipizide Glipizide Carbamazepine may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide The risk or severity of adverse effects can be increased when Indapamide is combined with Carbamazepine.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dicloxacillin Dicloxacillin The metabolism of Carbamazepine can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Carbamazepine can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Pentoxifylline Pentoxifylline The serum concentration of Pentoxifylline can be decreased when it is combined with Carbamazepine.
Pentamidine Injection Pentamidine Injection The metabolism of Carbamazepine can be decreased when combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Gemfibrozil Gemfibrozil Carbamazepine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz The metabolism of Guanabenz can be increased when combined with Carbamazepine.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Carbamazepine.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Amiodarone Amiodarone The metabolism of Amiodarone can be increased when combined with Carbamazepine.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Buspirone Buspirone The metabolism of Carbamazepine can be decreased when combined with Buspirone.
Lovastatin Lovastatin The metabolism of Carbamazepine can be decreased when combined with Lovastatin.
Ciprofloxacin Ciprofloxacin The serum concentration of Carbamazepine can be increased when it is combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Diclofenac Diclofenac The metabolism of Diclofenac can be increased when combined with Carbamazepine.
Fluoxetine Fluoxetine The serum concentration of Carbamazepine can be increased when it is combined with Fluoxetine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Carbamazepine.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Carbamazepine is combined with Clozapine.
Estazolam Estazolam Carbamazepine may increase the Change in thyroid function activities of Estazolam.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Carbamazepine is combined with Idarubicin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fludarabine.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Carbamazepine.
Clarithromycin Clarithromycin The metabolism of Carbamazepine can be decreased when combined with Clarithromycin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Felodipine Felodipine The metabolism of Carbamazepine can be decreased when combined with Felodipine.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Nabumetone Nabumetone The metabolism of Carbamazepine can be increased when combined with Nabumetone.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Carbamazepine.
Teniposide Injection Teniposide Injection The metabolism of Carbamazepine can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Carbamazepine can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Rifabutin Rifabutin The metabolism of Carbamazepine can be increased when combined with Rifabutin.
Bisoprolol Bisoprolol Carbamazepine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.
Doxazosin Doxazosin The metabolism of Carbamazepine can be increased when combined with Doxazosin.
Isradipine Isradipine The metabolism of Carbamazepine can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Carbamazepine can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Carbamazepine can be decreased when combined with Cisapride.
Gabapentin Gabapentin Carbamazepine may increase the Change in thyroid function activities of Gabapentin.
Fluvastatin Fluvastatin The metabolism of Carbamazepine can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Famciclovir Famciclovir The metabolism of Carbamazepine can be increased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The serum concentration of Nefazodone can be decreased when it is combined with Carbamazepine.
Lamotrigine Lamotrigine The metabolism of Lamotrigine can be increased when combined with Carbamazepine.
Losartan Losartan The metabolism of Carbamazepine can be decreased when combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tramadol Tramadol The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Carbamazepine can be increased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Carbamazepine.
Lansoprazole Lansoprazole The metabolism of Carbamazepine can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Carbamazepine.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Carbamazepine.
Nicardipine Nicardipine The metabolism of Nicardipine can be decreased when combined with Carbamazepine.
Bupropion Bupropion Carbamazepine may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be increased when combined with Carbamazepine.
Saquinavir Saquinavir The serum concentration of Carbamazepine can be decreased when it is combined with Saquinavir.
Metformin Metformin Metformin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Carbamazepine.
Nisoldipine Nisoldipine The metabolism of Carbamazepine can be decreased when combined with Nisoldipine.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Riluzole Riluzole Carbamazepine may increase the Change in thyroid function activities of Riluzole.
Acarbose Acarbose Acarbose may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Carbamazepine.
Indinavir Indinavir The serum concentration of Carbamazepine can be decreased when it is combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Carbamazepine can be decreased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Carbamazepine can be decreased when combined with Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Clomipramine Clomipramine The serum concentration of Clomipramine can be increased when it is combined with Carbamazepine.
Zafirlukast Zafirlukast The metabolism of Carbamazepine can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Mirtazapine Mirtazapine Carbamazepine may increase the serotonergic activities of Mirtazapine.
Topiramate Topiramate The therapeutic efficacy of Topiramate can be decreased when used in combination with Carbamazepine.
Zileuton Zileuton The metabolism of Zileuton can be increased when combined with Carbamazepine.
Pramipexole Pramipexole Carbamazepine may increase the sedative activities of Pramipexole.
Donepezil Donepezil The risk or severity of adverse effects can be increased when Carbamazepine is combined with Donepezil.
Nelfinavir Nelfinavir The serum concentration of Carbamazepine can be decreased when it is combined with Nelfinavir.
Azithromycin Azithromycin The metabolism of Carbamazepine can be increased when combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Carvedilol can be increased when combined with Carbamazepine.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Flutamide Flutamide The metabolism of Carbamazepine can be decreased when combined with Flutamide.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Carbamazepine is combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Carbamazepine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of adverse effects can be increased when Carbamazepine is combined with Sertraline.
Propafenone Propafenone The metabolism of Propafenone can be increased when combined with Carbamazepine.
Raloxifene Raloxifene The metabolism of Carbamazepine can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Carbamazepine can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin Carbamazepine may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ropinirole.
Finasteride Finasteride The metabolism of Carbamazepine can be decreased when combined with Finasteride.
Quetiapine Quetiapine The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Carbamazepine.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Citalopram Citalopram Carbamazepine may increase the QTc-prolonging activities of Citalopram.
Capecitabine Capecitabine The metabolism of Capecitabine can be increased when combined with Carbamazepine.
Efavirenz Efavirenz The metabolism of Carbamazepine can be increased when combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Carbamazepine can be decreased when combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Carbamazepine.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Tolterodine Tolterodine Carbamazepine may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Nateglinide Nateglinide The metabolism of Carbamazepine can be decreased when combined with Nateglinide.
Levetiracetam Levetiracetam The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.
Rabeprazole Rabeprazole The metabolism of Carbamazepine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Carbamazepine can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists